Godzilla: Final Wars (2004) inflation-adjusted box office: ₹22 standard Crores, admissions reach: 0.1 Crore footfalls (PAX),Khara rating: 60%, film industry: Hollywood, USA 🇺🇸.


Original Title: Gojira vs. Biorante
₹17.78 sCr$8.18 s$M
₹250 ATP Baseline Standard$8.18 s$M
Global Parity Normalized0.07 Cr PAX
After the previous Godzilla attack, a miniature arms race ensues to collect his cells. Concerned over Godzilla's possible return, the Japanese government uses the cells to create a new bio-weapon, ANEB (Anti-Nuclear Energy Bacteria). They seeks the aid of geneticist Genshiro Shiragami, who's experiments result in a new mutation.
Adjust the slider to simulate what Godzilla vs. Biollante's 0.07 Cr footfalls would earn at different era ticket prices.
World population was 5.224B in 1989 vs 8.2B today (2026). Toggle to scale admissions to today's population.
₹17.8 Cr
Standard ₹250 Purchasing Power across modern nationwide cinemas.
Konsa’s Khara Score measures honest theatrical longevity and repeat audience demand. Cast your community vote:
Compare Godzilla vs. Biollante (1989) against all-time cinema giants:
Explore the cinematic filmography and box office trajectory of Kazuki Ômori, Kôji Hashimoto, Kenjirô Ohmori
Highest inflation-adjusted real grosses across all Action cinema
Theatrical giants that defined cinema in 1989
Highest grossing theatrical phenomenon from Hollywood, USA 🇺🇸